Nitika Pharma Pioneers USFDA Compliance on Cancer-Linked Excipients, Strengthening Global Dominance

Опубликовано: 03 Июнь 2026
на канале: The New Indian
265
7

#InternationalPharmaceuticalsExhibition #NitikaPharmaceuticals #PharmaceuticalExcipients #GlobalMarket #USFDARegulations #NitrosamineStandards #PharmaCompliance

At the 10th International Pharmaceuticals Exhibition in Greater Noida, The New Indian talks to Nitika Pharmaceuticals. They share that the recent regulations by the USFDA address high nitrosamine levels in Excerpients—compounds linked to cancer found in some excipients. Nitika is among the first Indian companies to fully comply with these stringent new standards, ensuring product safety and quality. With a broad presence across India, Nitika meets the updated regulatory requirements, critical for pharmaceutical formulations entering the US market.


SUBSCRIBE for the Latest News:    / thenewindian  

Like, Comment and Share with your friends and family.

Facebook :  / thenewindianofficial  
Twitter : https://twitter.com/TheNewIndian_in?s=20
Instagram :   / thenewindian_in  
Koo: https://www.kooapp.com/profile/thenew...